Taken together, our results showed that overexpression of ZEB1 could transcriptionally suppress the expression of ERα and miR-190 and led to SOX9 elevation and activation of Wnt/β-catenin signaling, resulting in anti-estrogen resistance therapies in breast cancer. The gene discussed is ZEB1; the disease is breast carcinoma.